Strateos
Private Company
Total funding raised: $86M
Overview
Strateos has pioneered the concept of the 'cloud lab' or 'remote-access automated laboratory,' a platform that allows scientists to design, execute, and analyze experiments entirely through a software interface. Its technology integrates laboratory robotics, instrumentation, and data management into a unified, programmable environment, aiming to accelerate research cycles and improve reproducibility. The company primarily serves biopharma, biotech, and academic institutions seeking to scale their R&D operations without significant capital expenditure in physical infrastructure. By digitizing the experimental workflow, Strateos positions itself as a key enabler for the digital transformation of life sciences.
Technology Platform
Cloud-based, software-defined robotic laboratory platform enabling remote design, execution, and data analysis of life science experiments via API/GUI.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Strateos competes with large lab automation vendors (e.g., Thermo Fisher, Agilent), traditional contract research organizations (CROs) investing in automation, and a new wave of tech-bio companies. Its primary differentiation is its fully integrated, cloud-native platform and remote-access 'lab as a service' model, unlike point-solution automation or on-premise CRO services.